NeuroNEXT Small Business Innovation in Clinical Trials (U44 Clinical Trial Optional)

基金名称
NeuroNEXT Small Business Innovation in Clinical Trials (U44 Clinical Trial Optional)
资助机构
HHS-NIH11(National Institutes of Health)
研究领域
Health
截止日期
April 5, 2024 (已过期)
基金规模
$1,000,000
联系方式
National Institutes of Health grantsinfo@nih.gov
申请资格
Small businesses, Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, may be allowed.
基金编号
PAR-21-224
说明
This Funding Opportunity Announcement (FOA) encourages small business applications for exploratory clinical trials of investigational agents (drugs, biologics, surgical therapies or devices) that may contribute to the justification for and provide the data required for designing clinical studies. Diseases chosen for study should be based on the NINDS strategic plan and clinical research interests (www.ninds.nih.gov/funding/areas/index.htm).

基金资源

NIH General Instructions 下载文件
NIH Application Guide 打开链接
Purdue Grant Writing Lab: Introduction to Grant Writing 打开链接
University of Wisconsin Writing Center: Planning and Writing a Grant Proposal 打开链接

快速分享


将截止日期添加到日历

April 5, 2024

你有想要在此列出的基金申报机会吗?

立即提交你的基金合作意向,发送至 support@peeref.com,我们会尽快为你审核。


Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started